MASH / MASLD
Post-Rezdiffra field: FGF21s, GLP-1 combos, and fibrosis-focused assets.
Lenses
EarlierApproval →
MDGLApprovedcash ok
2026-11-01 (80d)Company-guided
Rezdiffra · NCT03900429 · Label / real-world update
AKROPh3cash ok
2026-10-25 (73d)Company-guided
Efruxifermin · NCT05039450 · Phase 3 histology
VKTXPh2cash ok
2027-01-10 (150d)Estimated
VK2809 THR-β · NCT04173065 · MASH dataset
GILDPh2cash ok
2027-03-15 (214d)Estimated
MASH pipeline option · NCT04951219 · Liver pipeline update